ArticleArquivos brasileiros de cardiologia2026
Hyperkalemia in Heart Failure Hospitalizations: An Underreported Contributor to Poor Outcomes and Higher Costs in Brazil.
Article in Arquivos brasileiros de cardiologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperkalemia is associated with poor prognosis in heart failure (HF), but its reporting in administrative data is likely suboptimal. The aim was to evaluate the frequency and impact of hyperkalemia ICD coding during HF hospitalizations in Brazil. We analyzed 3,551,738 HF hospitalizations from the DATASUS database (2008-2024). ICD codes were used to identify hyperkalemia. Logistic and Cox regression analyses assessed associations between comorbidities, outcomes, and resource utilization. Only 491 hospitalizations (0.014%) were coded for hyperkalemia. These patients were older (mean 70.3 vs. 66.6 years) and had higher rates of chronic kidney disease, diabetes, and cardiovascular disease. Hyperkalemia was associated with increased in-hospital mortality (25% vs. 10%), ICU admissions (17% vs. 11%), dialysis (11% vs. 1%), and longer ICU stays (9.45 vs. 5.36 days). Average costs were 59% higher (2,402 vs. 1,512 BRL). Hyperkalemia is severely underreported in Brazilian HF hospitalizations, despite being a clear marker of clinical severity and higher resource use. Improved awareness and coding may support better outcomes and planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.